Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells

被引:55
作者
Hansen, KK
Saifeddine, M
Hollenberg, MD
机构
[1] Univ Calgary, Fac Med, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Fac Med, Dept Med, Calgary, AB T2N 4N1, Canada
关键词
enzymes; proteases; proteinases; proteins; peptides; tethered ligands; VAV-1; signalling; calcium; PARs; tyrosine phosphorylation; T cells : Jurkat cells;
D O I
10.1111/j.1365-2567.2004.01870.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Proteinase-activated receptors (PARs) can activate a number of signalling events, including T-cell signal-transduction pathways. Recent data suggest that the activation of PARs 1, 2 and 3 in Jurkat T-leukaemic cells induces tyrosine phosphorylation of the haematopoietic signal transducer protein, VAV1. To activate the PARs, this study used the agonist peptides SFLLRNPNDK, SLIGKVDGTS and TFRGAPPNSF, which are based on the sequences of the tethered ligand sequences of human PARs 1, 2 and 3, respectively. Here, we show that peptides based on either the human or murine PAR(3)-derived tethered ligand sequences (TFRGAP-NH2 or SFNGGP-NH2) do not activate PAR(3), but rather activate PARs 1 and 2, either in Jurkat or in other PAR-expressing cells. Furthermore, whilst thrombin activates only Jurkat PAR(1), trypsin activates both PARs 1 and 2 and also disarms Jurkat PAR(1) for thrombin activation. We conclude therefore that in Jurkat or related T cells, signalling via PARs that can affect VAV1 phosphorylation is mediated via PAR 1 or 2, or both, and that distinct serine proteinases may potentially differentially affect T-cell function in the settings of inflammation.
引用
收藏
页码:183 / 190
页数:8
相关论文
共 26 条
[1]  
Al-Ani B, 1999, J PHARMACOL EXP THER, V290, P753
[2]   Proteinase activated receptor 2: role of extracellular loop 2 for ligand-mediated activation [J].
Al-Ani, B ;
Saifeddine, M ;
Kawabata, A ;
Hollenberg, MD .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (05) :1105-1113
[3]   Signalling pathways induced by protease-activated receptors and integrins in T cells [J].
Bar-Shavit, R ;
Maoz, M ;
Yin, YJ ;
Groysman, M ;
Dekel, I ;
Katzav, S .
IMMUNOLOGY, 2002, 105 (01) :35-46
[4]   Ligand cross-reactivity within the protease-activated receptor family [J].
Blackhart, BD ;
Emilsson, K ;
Nguyen, D ;
Teng, W ;
Martelli, AJ ;
Nystedt, S ;
Sundelin, J ;
Scarborough, RM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16466-16471
[5]  
BRASS LF, 1992, J BIOL CHEM, V267, P13795
[6]   A polymorphic protease-activated receptor 2 (PAR2) displaying reduced sensitivity to trypsin and differential responses to PAR agonists [J].
Compton, SJ ;
Cairns, JA ;
Palmer, KJ ;
Al-Ani, B ;
Hollenberg, MD ;
Walls, AF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) :39207-39212
[7]   Glycosylation and the activation of proteinase-activated receptor 2 (PAR2) by human mast cell tryptase [J].
Compton, SJ ;
Renaux, B ;
Wijesuriya, SJ ;
Hollenberg, MD .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (04) :705-718
[8]   Thrombin signalling and protease-activated receptors [J].
Coughlin, SR .
NATURE, 2000, 407 (6801) :258-264
[9]   Proteinase-activated receptors:: novel mechanisms of signaling by serine proteases [J].
Déry, O ;
Corvera, CU ;
Steinhoff, M ;
Bunnett, NW .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 274 (06) :C1429-C1452
[10]   Vav links antigen-receptor signaling to the actin cytoskeleton [J].
Fischer, KD ;
Tedford, K ;
Penninger, JM .
SEMINARS IN IMMUNOLOGY, 1998, 10 (04) :317-327